Ank2tm2.1Bnt
Targeted Allele Detail
|
Symbol: |
Ank2tm2.1Bnt |
Name: |
ankyrin 2, brain; targeted mutation 2.1, Vann Bennett |
MGI ID: |
MGI:5646021 |
Synonyms: |
Ank2L1622I, Ank2tm2.1(L1622I)Bnt |
Gene: |
Ank2 Location: Chr3:126715261-127292999 bp, - strand Genetic Position: Chr3, 56.07 cM
|
Alliance: |
Ank2tm2.1Bnt page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:222913
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
129
|
|
Allele Type: |
|
Targeted (Humanized sequence) |
Mutations: |
|
Insertion, Nucleotide substitutions
|
|
|
Mutation details: An L1622I (CTG to ATC) mutation in exon 19 and a loxP site flanked neomycin resistance gene cassette were knocked into the gene. In humans, the mutation is involved with the setting of hereditary cardiac arrhythmia. Cre-mediated recombination removed the neo cassette. Western blot analysis confirmed reduced protein expression in the fat, liver, skeletal muscle, pancreatic beta cells, mouse embryonic fibroblasts and heart but not the brain.
(J:222913)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Ank2 Mutation: |
185 strains or lines available
|
|
Original: |
J:222913 Lorenzo DN, et al., Ankyrin-B metabolic syndrome combines age-dependent adiposity with pancreatic beta cell insufficiency. J Clin Invest. 2015 Aug 3;125(8):3087-3102 |
All: |
1 reference(s) |
|